Catalyst Wire Dossier Catalyst Wire Dossier

Pelubiprofen IR tablet

pelubiprofen · Daewon Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pelubiprofen IR tablet, covering 2014-01-14 to 2014-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR and Pelubiprofen SR (as a Pelubiprofen 45 mg) Tablet in Healthy Subjects [Phase 1]

See pricing